RU96100754A - N - [[1- [4- / 4-FLUORPHENOXY / BUTYL] -4-PIPERIDINYL] -N-METHYLAMINO] -2-BENZOTHIAZOLOLES AS ANTI-ARITHM MEDICINE CLASS III - Google Patents

N - [[1- [4- / 4-FLUORPHENOXY / BUTYL] -4-PIPERIDINYL] -N-METHYLAMINO] -2-BENZOTHIAZOLOLES AS ANTI-ARITHM MEDICINE CLASS III

Info

Publication number
RU96100754A
RU96100754A RU96100754/04A RU96100754A RU96100754A RU 96100754 A RU96100754 A RU 96100754A RU 96100754/04 A RU96100754/04 A RU 96100754/04A RU 96100754 A RU96100754 A RU 96100754A RU 96100754 A RU96100754 A RU 96100754A
Authority
RU
Russia
Prior art keywords
compound according
piperidinyl
methylamino
butyl
compound
Prior art date
Application number
RU96100754/04A
Other languages
Russian (ru)
Other versions
RU2122546C1 (en
Inventor
Ян Питер Хейкантс Йозеф
Ян Мария Боргерс Марсель
Вильхельм Дорис
Original Assignee
Жансен Фармасетика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Жансен Фармасетика Н.В. filed Critical Жансен Фармасетика Н.В.
Publication of RU96100754A publication Critical patent/RU96100754A/en
Application granted granted Critical
Publication of RU2122546C1 publication Critical patent/RU2122546C1/en

Links

Claims (9)

1. Соединение, имеющее формулу I
Figure 00000001

где один из заместителей R1 и R2 представляет собой гидроксигруппу, тогда как другой обозначает водород, а также его фармацевтически приемлемые соли присоединения кислоты.
1. The compound having the formula I
Figure 00000001

where one of the substituents R 1 and R 2 represents a hydroxy group, while the other denotes hydrogen, as well as its pharmaceutically acceptable acid addition salts.
2. Соединение по п.1, которое представляет собой 2-[[1-[4-)-4-фторфенокси)бутил] 4-пиперидинил] метиламино]-5-бензотиазолол или его фармацевтически приемлемую соль присоединения кислоты. 2. The compound according to claim 1, which is 2 - [[1- [4 -) - 4-fluorophenoxy) butyl] 4-piperidinyl] methylamino] -5-benzothiazolol or its pharmaceutically acceptable acid addition salt. 3. Соединение по п. 1, которое представляет собой 2-[[1-[4-(4-фторфенокси)бутил] -4-пиперидинил] метиламино]-6-бензотиазолол или его фармацевтически приемлемую соль добавления кислоты. 3. The compound according to claim 1, which is 2 - [[1- [4- (4-fluorophenoxy) butyl] -4-piperidinyl] methylamino] -6-benzothiazolol or its pharmaceutically acceptable acid addition salt. 4. Соединение по п. 1, которое представляет собой 2-[[1-[4-)4-фторфенокси)бутил]-4-пиперидинил]метиламино]-6-бензотиазолол (Z)-2-бутендиоат (1 : 1). 4. The compound according to claim 1, which is a 2 - [[1- [4-) 4-fluorophenoxy) butyl] -4-piperidinyl] methylamino] -6-benzothiazolol (Z) -2-bundioate (1: 1) . 5. Антиаритмическая композиция III класса, включающая фармацевтически приемлемый наполнитель и в качестве активного ингредиента терапевтически эффективное количество соединения по любому из пп.1 - 4. 5. An antiarrhythmic composition of class III, including a pharmaceutically acceptable excipient and, as an active ingredient, a therapeutically effective amount of a compound according to any one of claims 1 to 4. 6. Способ получения композиции по п.4, отличающийся тем, что включает тщательное перемешивание терапевтически эффективного количества соединения по пп.1 - 4 с фармацевтически приемлемым наполнителем. 6. A method of obtaining a composition according to claim 4, characterized in that it includes thoroughly mixing a therapeutically effective amount of a compound according to claims 1-4 with a pharmaceutically acceptable excipient. 7. Соединение по любому из пп.1 - 4, предназначенное для использования в медицине. 7. The compound according to any one of paragraphs.1 to 4, intended for use in medicine. 8. Соединение по любому из пп.1 - 4, предназначенное для использования в качестве антиаритмических средств III класса. 8. The compound according to any one of paragraphs.1 to 4, intended for use as an antiarrhythmic agent of class III. 9. Способ приготовления соединения по п.1, отличающийся тем, что осуществляют N-алкилирование промежуточного соединения формулы II в том случае, когда один из двух заместителей R1 и R2 представляет собой гидроксигруппу, а другой - водород, реагентом формулы III, в которой W обозначает отщепляемую реакционную группу
Figure 00000002

а также при необходимости, превращение соединения формулы I в терапевтически активную метоксичную соль присоединения кислоты или, наоборот, превращение упомянутого соединения в виде соли присоединения кислоты в свободное основание путем обработки щелочью.
9. The method of preparation of the compound according to claim 1, characterized in that N-alkylation of the intermediate compound of formula II is carried out in the case when one of the two substituents R 1 and R 2 is a hydroxy group, and the other is hydrogen, with a reagent of formula III wherein W denotes a leaving group
Figure 00000002

and, if necessary, the conversion of a compound of formula I into a therapeutically active methoxy acid addition salt or, conversely, the conversion of said compound in the form of an acid addition salt into a free base by treatment with alkali.
RU96100754A 1993-06-11 1994-06-06 N-[[1-[4-(fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino]-2-benzthiazoles or their pharmaceutically acceptable acid salts, a method of synthesis, an antiarrhythmic composition of the third-class and a method of its preparing RU2122546C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201685.0 1993-06-11
EP93201685 1993-06-11

Publications (2)

Publication Number Publication Date
RU96100754A true RU96100754A (en) 1998-03-27
RU2122546C1 RU2122546C1 (en) 1998-11-27

Family

ID=8213890

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96100754A RU2122546C1 (en) 1993-06-11 1994-06-06 N-[[1-[4-(fluorophenoxy)butyl]-4-piperidinyl]-n-methylamino]-2-benzthiazoles or their pharmaceutically acceptable acid salts, a method of synthesis, an antiarrhythmic composition of the third-class and a method of its preparing

Country Status (34)

Country Link
US (1) US5691354A (en)
EP (1) EP0701556B1 (en)
JP (1) JP3498145B2 (en)
KR (1) KR100337984B1 (en)
CN (1) CN1039120C (en)
AT (1) ATE159254T1 (en)
AU (1) AU678841B2 (en)
BG (1) BG62968B1 (en)
BR (1) BR9406765A (en)
CA (1) CA2163018A1 (en)
CZ (1) CZ285766B6 (en)
DE (1) DE69406284T2 (en)
DK (1) DK0701556T3 (en)
ES (1) ES2108471T3 (en)
FI (1) FI955916A (en)
GR (1) GR3025805T3 (en)
HU (1) HU221620B1 (en)
IL (1) IL109975A (en)
LV (1) LV11544B (en)
MY (1) MY111222A (en)
NO (1) NO305123B1 (en)
NZ (1) NZ268575A (en)
OA (1) OA10201A (en)
PH (1) PH31126A (en)
PL (1) PL176775B1 (en)
RO (1) RO115523B1 (en)
RU (1) RU2122546C1 (en)
SG (1) SG48821A1 (en)
SI (1) SI9420036A (en)
SK (1) SK281175B6 (en)
TW (1) TW282469B (en)
UA (1) UA41936C2 (en)
WO (1) WO1994029305A1 (en)
ZA (1) ZA944106B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398388A1 (en) * 2000-01-20 2001-07-26 Koji Kato Novel piperidine compound and pharmaceutical thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (en) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. Process for preparing substituted n-|(4-piperidinyl) alkyl¨ bicycle condensed oxazole and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Similar Documents

Publication Publication Date Title
RU2695274C3 (en) NEW COMPOSITIONS AND METHODS FOR THEIR STABILIZATION
BR8201589A (en) COMPOUND, PHARMACEUTICAL COMPOSITION, PROCESS TO TREAT AND / OR AVOID HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE PASTE PASTE AND ASMA IN A MAMMAL AND PROCESS FOR THE PREPARATION OF TAL
ATE137753T1 (en) CODEINE SALT OF A SUBSTITUTED CARBOXIC ACID, METHOD FOR THE PRODUCTION THEREOF, ITS USE AND PHARMACEUTICAL PREPARATIONS
RU2003134629A (en) CEPHEMA COMPOUNDS
RU96109699A (en) GUANIDIDES OF ALKENILKARBONIC ACIDS, METHOD OF THEIR RECEIVING, CONTAINING THEIR MEDICATION OR DIAGNOSTIC TOOL
ES8607218A1 (en) Novel amidine compounds.
RU96100754A (en) N - [[1- [4- / 4-FLUORPHENOXY / BUTYL] -4-PIPERIDINYL] -N-METHYLAMINO] -2-BENZOTHIAZOLOLES AS ANTI-ARITHM MEDICINE CLASS III
EP0168921A3 (en) Chemical compounds
DK0626367T3 (en) (7S) -7- (2R) -2- (3-Chlorophenyl) -2-hydroxyethylamino -5,6,7,8-tetrahydronaphthalen-2-yloxyacetic acid and pharmaceutically acceptable salts thereof with beta3-adrenergic agonist activity, pharmaceutical preparations and laboratory reagents which contains it.
ATE45738T1 (en) 1-CYCLOPROPYL-1,4-DIHYDRO-4-OXO-7-(4-(2-OXO-1,3DIOXOL-4-YL-METHYL)-1-PIPERAZINYL>-3QUINOLINECARBONICURIES, PROCESS FOR THEIR PREPARATION AND THIS CONTAINS ANTIBACTERIAL AGENTS.
RU96101187A (en) Positive myotropic and luzitropic derivatives of pyrrolochinolinone
IL153784A0 (en) Novel n-(2-phenyl-3-aminopropyl) naphthamides
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
KR940021524A (en) 1,2,5,6-tetrahydropyridine derivatives, preparation method thereof and use thereof in treatment
ES527241A0 (en) A PROCEDURE FOR PREPARING 1-AROIL-5-OXO-2-PIRROLIDIN-PROPANOIC ACID DERIVATIVES
TW223065B (en)
UY26971A1 (en) NEW NEUROQUININE ANTAGONISTS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
MY111222A (en) N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methyl-amino]-2-benzothiazolols as class iii antiarrhythmic agents.
RU95113184A (en) Derivatives substituted
ATE418985T1 (en) TREATMENT OF PSYCHOSTIMULANT ADDICTION
KR900014372A (en) Thienyl piperazine preparation method and pharmaceutical agent containing same
TH51747A (en) Monocyclic benzamides of derivatives 4- (aminomethyl) piperidine Which is replaced at position 3- or 4-
TH1446EX (en) Preparation of various chlorobenzylphoxylcoxilic compounds
RU97102152A (en) SULPHONAMIDE DERIVATIVES OF AZOLONES, ACTING AGAINST HELICOBACTER
RU98114488A (en) SUBSTITUTED 6-H-1,3,4-TIADIAZIN-2-AMINES, THEIR APPLICATION AS ANESTHETIC, CARDIOVASCULAR AND HYPOMETABOLIC MEANS AND CONTAINING THEIR PHARMACEUTICAL CHEMICALS